277 related articles for article (PubMed ID: 17499752)
1. Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression.
Bianchini F; Massi D; Marconi C; Franchi A; Baroni G; Santucci M; Mannini A; Mugnai G; Calorini L
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):320-8. PubMed ID: 17499752
[TBL] [Abstract][Full Text] [Related]
2. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors.
Massi D; Marconi C; Franchi A; Bianchini F; Paglierani M; Ketabchi S; Miracco C; Santucci M; Calorini L
Hum Pathol; 2007 Oct; 38(10):1516-25. PubMed ID: 17640716
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression.
Kuźbicki L; Sarnecka A; Chwirot BW
Melanoma Res; 2006 Feb; 16(1):29-36. PubMed ID: 16432453
[TBL] [Abstract][Full Text] [Related]
4. Tumor progression in the human melanocytic system.
Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of cyclooxygenage-2 in melanocytic skin lesions.
Minami S; Lum CA; Kitagawa KM; Namiki TS
Int J Dermatol; 2011 Jan; 50(1):24-9. PubMed ID: 21182498
[TBL] [Abstract][Full Text] [Related]
6. Expression of thyrotropin-releasing hormone by human melanoma and nevi.
Ellerhorst JA; Naderi AA; Johnson MK; Pelletier P; Prieto VG; Diwan AH; Johnson MM; Gunn DC; Yekell S; Grimm EA
Clin Cancer Res; 2004 Aug; 10(16):5531-6. PubMed ID: 15328193
[TBL] [Abstract][Full Text] [Related]
7. Resident peritoneal macrophages and mast cells are important cellular sites of COX-1 and COX-2 activity during acute peritoneal inflammation.
Kolaczkowska E; Goldys A; Kozakiewicz E; Lelito M; Plytycz B; van Rooijen N; Arnold B
Arch Immunol Ther Exp (Warsz); 2009; 57(6):459-66. PubMed ID: 19885646
[TBL] [Abstract][Full Text] [Related]
8. Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth.
Tsai CS; Chen FH; Wang CC; Huang HL; Jung SM; Wu CJ; Lee CC; McBride WH; Chiang CS; Hong JH
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):499-507. PubMed ID: 17398016
[TBL] [Abstract][Full Text] [Related]
9. Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma.
Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
Arch Dermatol Res; 2005 Oct; 297(4):154-60. PubMed ID: 16047212
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner.
Chen P; Huang Y; Bong R; Ding Y; Song N; Wang X; Song X; Luo Y
Clin Cancer Res; 2011 Dec; 17(23):7230-9. PubMed ID: 21994414
[TBL] [Abstract][Full Text] [Related]
11. Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma.
Fröhlich E; Schlagenhauff B; Möhrle M; Weber E; Klessen C; Rassner G
Cancer; 2001 Mar; 91(5):972-82. PubMed ID: 11251949
[TBL] [Abstract][Full Text] [Related]
12. PUMA expression is significantly reduced in human cutaneous melanomas.
Karst AM; Dai DL; Martinka M; Li G
Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
[TBL] [Abstract][Full Text] [Related]
13. COX-2 induction by heparanase in the progression of breast cancer.
Imada T; Matsuoka J; Nobuhisa T; Okawa T; Murata T; Tabuchi Y; Shirakawa Y; Ohara N; Gunduz M; Nagatsuka H; Umeoka T; Yamamoto Y; Nakajima M; Tanaka N; Naomoto Y
Int J Mol Med; 2006 Feb; 17(2):221-8. PubMed ID: 16391819
[TBL] [Abstract][Full Text] [Related]
14. COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness.
Scarpino S; Duranti E; Stoppacciaro A; Pilozzi E; Natoli G; Sciacchitano S; Luciani E; Ruco L
J Pathol; 2009 Aug; 218(4):487-94. PubMed ID: 19391129
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 immunohistochemistry in human melanoma: differences between results obtained with different antibodies.
Kuzbicki L; Lange D; Chwirot BW
Melanoma Res; 2009 Oct; 19(5):294-300. PubMed ID: 19543125
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of cyclooxygenase-2 (COX-2) in oral nevi and melanoma.
de Souza do Nascimento J; Carlos R; Delgado-Azañero W; Mosqueda Taylor A; de Almeida OP; Romañach MJ; de Andrade BA
J Oral Pathol Med; 2016 Jul; 45(6):440-3. PubMed ID: 26608958
[TBL] [Abstract][Full Text] [Related]
17. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
18. A high percentage of skin melanoma cells expresses SPANX proteins.
Salemi M; Calogero AE; Vicari E; Migliore E; Zaccarello G; Cosentino A; Amore M; Tricoli D; Castiglione R; Bosco P; Rappazzo G
Am J Dermatopathol; 2009 Apr; 31(2):182-6. PubMed ID: 19318807
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclo-oxygenase-2 in gastrointestinal carcinoid tumors.
Mizuno S; Kato K; Hashimoto A; Sugitani M; Sheikh A; Komuro S; Jike T; Iwasaki A; Arakawa Y; Nemoto N
J Gastroenterol Hepatol; 2006 Aug; 21(8):1313-9. PubMed ID: 16872316
[TBL] [Abstract][Full Text] [Related]
20. COX-2 expression in malignant melanoma: a novel prognostic marker?
Becker MR; Siegelin MD; Rompel R; Enk AH; Gaiser T
Melanoma Res; 2009 Feb; 19(1):8-16. PubMed ID: 19430402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
